Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36652354

Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 Jan 19
First author
Goyal L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):790-794. doi: 10.21037/hbsn-23-411.
    note
    Source null
    related pmid
    37886210
    relationship
    Comment in
  2. citation
    Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):923-926. doi: 10.21037/hbsn-23-476.
    note
    Source null
    related pmid
    38115933
    relationship
    Comment in

Authors and identifiers

  1. name
    Goyal L
    type
    Author
  2. name
    Meric-Bernstam F
    type
    Author
  3. name
    Hollebecque A
    type
    Author
  4. name
    Valle JW
    type
    Author
  5. name
    Morizane C
    type
    Author
  6. name
    Karasic TB
    type
    Author
  7. name
    Abrams TA
    type
    Author
  8. name
    Furuse J
    type
    Author
  9. name
    Kelley RK
    type
    Author
  10. name
    Cassier PA
    type
    Author
  11. name
    Klümpen HJ
    type
    Author
  12. name
    Chang HM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Goyal L
    type
    Author
  2. name
    Meric-Bernstam F
    type
    Author
  3. name
    Hollebecque A
    type
    Author
  4. name
    Valle JW
    type
    Author
  5. name
    Morizane C
    type
    Author
  6. name
    Karasic TB
    type
    Author
  7. name
    Abrams TA
    type
    Author
  8. name
    Furuse J
    type
    Author
  9. name
    Kelley RK
    type
    Author
  10. name
    Cassier PA
    type
    Author
  11. name
    Klümpen HJ
    type
    Author
  12. name
    Chang HM
    type
    Author
bibliography ids
  1. nci-bib-2f8153dd9174e1cde5bc90f4
book metadata
content sha256
200e59e4b1f9606732ed5ebe7d0a208fb761dcecc433586ddaf53e8b341f9469
document type
citation
dois
  1. 10.1056/NEJMoa2206834
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:36652354
immutable id
pubmed:36652354@200e59e4b1f9606732ed5ebe7d0a208fb761dcecc433586ddaf53e8b341f9469
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
3
name
The New England journal of medicine
nlm unique id
0255562
pages
228-239
volume
388
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):790-794. doi: 10.21037/hbsn-23-411.
    note
    Source null
    related pmid
    37886210
    relationship
    Comment in
  2. citation
    Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):923-926. doi: 10.21037/hbsn-23-476.
    note
    Source null
    related pmid
    38115933
    relationship
    Comment in
outcomes validated
false
pmid
36652354
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
89c5b5dfcb2884a59ca83d8bdb319e3bd6d714f673b166168e5aecc206458354
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Jan 19
precision
day
year
2023
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36652354/
title
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.

Preserved source evidence · Not medical advice